The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 3 to 6 against recommending camizestrant in combination with a CDK4/6 inhibitor
The summit will bring together 1,200+ delegates, 100+ international faculty from 25 countries
Collaboration to accelerate mRNA neoantigen therapy development for colorectal and pancreatic cancers using advanced immunology and dark genome insights
Multidisciplinary team expansion brings integrated medical, surgical, and radiation oncology services under one roof
Aims to boost speed & precision in patient care
Experts highlighted how robotic-assisted procedures are improving surgical precision, reducing complications, and enabling faster recovery
Move to accelerate cancer care expansion across India
A major push to sharpen the future of cancer treatment is underway
The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation
The initiative aligns with global psycho-oncology standards that advocate routine distress screening as a core quality benchmark in cancer treatment
Subscribe To Our Newsletter & Stay Updated
